Cyclacel announces amendment to exchange agreement with Fitters

Written by Emily J. Thompson, Senior Investment Analyst

CYCC%

Updated: Jul 07 2025

0mins

Transaction Details: Cyclacel Pharmaceuticals has amended its Exchange Agreement with FITTERS Diversified Berhad, allowing for the exchange of shares from FITTERS' subsidiary for common stock in Cyclacel, along with a cash payment of $1,000,000 at closing.
Approval and Timeline: The agreement has been unanimously approved by the Boards of Directors of both companies and is subject to approval from stockholders, with the final date for the transaction extended to September 30, 2025.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Cyclacel announces amendment to exchange agreement with Fitters

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Pictet North America Advisors Buys 2,703 Shares of MercadoLibre (MELI) for $5.68 Million

Louisbourg Investments Sells 73,600 Shares of OR Royalties for Approximately $2.58 Million

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch